Tracleer and Tumor - a phase IV clinical study of FDA data

Summary:

Tumor is reported as a side effect among people who take Tracleer (bosentan), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Coumadin, and have Pulmonary hypertension.

The phase IV clinical study analyzes which people have Tumor when taking Tracleer. It is created by eHealthMe based on reports of 55,065 people who have side effects when taking Tracleer from the FDA, and is updated regularly.

What is Tracleer?

Tracleer has active ingredients of bosentan. It is often used in primary pulmonary hypertension. eHealthMe is studying from 55,125 Tracleer users. Check the latest studies of Tracleer.

What is Tumor?

Tumor is found to be associated with 1,407 drugs and 1,707 conditions by eHealthMe. Check the latest studies of Tumor.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

55,065 people reported to have side effects when taking Tracleer.
Among them, 47 people (0.09%) have Tumor.

Among these 47 people:

How long have people been on Tracleer when they have Tumor? *

What is the gender of people who have Tumor when taking Tracleer? *

female: 76.92 %
male: 23.08 %

What is the age of people who have Tumor when taking Tracleer? *

What are other drugs people take besides Tracleer? *

What are other side effects people have besides Tumor? *

Haemorrhage (bleeding): 8 people, 17.02%
Malaise (a feeling of general discomfort or uneasiness): 7 people, 14.89%
Fatigue (feeling of tiredness): 7 people, 14.89%
Back Pain: 6 people, 12.77%
Pneumonia: 6 people, 12.77%
Joint Pain: 6 people, 12.77%
Diarrhea: 6 people, 12.77%
Fall: 5 people, 10.64%
Pain: 5 people, 10.64%
Nausea And Vomiting: 5 people, 10.64%

What are the existing conditions these people have? *

Pulmonary Hypertension (increase in blood pressure in the lung artery): 6 people, 12.77%
Thyroid Diseases: 1 person, 2.13%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 2.13%
Seasonal Allergy (allergic condition due to certain season): 1 person, 2.13%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 2.13%
Osteoporosis (bones weak and more likely to break): 1 person, 2.13%
Oesophageal Carcinoma (cancer tumour of oesophagus): 1 person, 2.13%
Neuroendocrine Carcinoma (cancer tumour that arise from cells of the endocrine (hormonal) and nervous systems): 1 person, 2.13%
Hypersensitivity: 1 person, 2.13%
High Blood Pressure: 1 person, 2.13%

* Approximation only. Some reports may have incomplete information.

Do you take Tracleer and have Tumor?

- Check whether Tumor is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tracleer:

Tracleer (55,125 reports)

Tumor treatments and more:

Tumor (38,734 reports)

Browse all side effects of Tracleer:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tumor:

Tumor (1,407 drugs)

Browse all the conditions that are associated with Tumor:

Tumor (1,707 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bosentan (the active ingredients of Tracleer) and Tracleer (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.